11,067 Results

Somapacitan,once-weekly growth hormone derivative, showed in REAL 3, comparable efficacy, safety and tolerability to once-daily injections of Norditropin. Novo Nordisk

 Added 1 day ago

Novo Nordisk announced that somapacitan, a novel growth hormone derivative in development as a once-weekly treatment option, demonstrated comparable efficacy,...

CHMP recommends aproval of Xospata in FLT3+ acute myeloid leukemia.- Astellas Pharma

 Added 1 day ago

Astellas Pharma announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) has adopted...

FDA approves sNDA for Pifeltro in HIV.- Merck

 Added 1 day ago

Merck announced that the FDA approved supplemental New Drug Applications (sNDAs) for Pifeltro (in combination with other antiretroviral agents) that...

FDA approves sNDA for Delstrigo in HIV patients.- Merck

 Added 1 day ago

Merck announced that the FDA approved supplemental New Drug Application (sNDA) for Delstrigo (doravirine, tenofovir DF, 3TC (lamivudine) as a...

FDA approves oral Rybelsus for type 2 diabetes.- Novo Nordisk

 Added 1 day ago

Novo Nordisk announced that the FDA has approved Rybelsus (semaglutide) tablets 7 mg or 14 mg for adults with type...

Biogen announces a new trial DEVOTE to evaluate a higher dose of Spinraza for patients with spinal muscular atrophy.

 Added 1 day ago

Biogen Inc.has announced updates to the Spiraza (nusinersen) clinical development program including the initiation of a new global clinical trial,...

CHMP recommends Bavencio + axitinib for first line treatment of renal cell carcinoma. Merck KGaA + Pfizer

 Added 2 days ago

Merck KGaA and Pfizer Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...

CHMP recommends expansion of Trulicity label to include results from REWIND cardiovascular and diabetes outcomes trial.- Eli Lilly

 Added 2 days ago

Eli Lilly and Company announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) issued a...

CHMP recommends Dupixent to treat adults with severe chronic rhinosinusitis with nasal polyposis. Sanofi

 Added 2 days ago

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Dupixent (dupilumab)...

FDA accepts Merck’s BLA and grants priority review for V 920, the investigational vaccine for Ebola Zaire Virus.

 Added 2 days ago

Merck Inc., announced that the FDA has accepted the Biologics License Application (BLA) and granted priority review for Merck’s investigational...

Load more